Quality-of-life and performance status results from the phase III RAINBOW study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated gastric or gastroesophageal junction adenocarcinoma
| Autor: | Al-Batran, S.-E. *, Van Cutsem, E., Oh, S.C., Bodoky, G., Shimada, Y., Hironaka, S., Sugimoto, N., Lipatov, O.N., Kim, T.-Y., Cunningham, D., Rougier, P., Muro, K., Liepa, A.M., Chandrawansa, K., Emig, M., Ohtsu, A., Wilke, H. |
|---|---|
| Zdroj: | In Annals of Oncology April 2016 27(4):673-679 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|